Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
When faith comes under fire: How Iran’s repression of religious minorities has increased - 2Lockheed Martin opens new hypersonic weapons facility
- 3Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
- 4Believe Should Unwind? Look at These Scaled down Games
- 5Warming winters lead to more nitrate pollution in the drinking water near farms
- Very good quality Greens All over The Planet
- New electric car registrations rise sharply in Germany in March
- Cruising Solo All over the Planet: An Excursion of Self-Disclosure
- Navy-Marine Corps Relief Society provides emergency grants to families displaced by Iran war
- India's top court hears challenges to ruling on women's entry into temple
- Disability rights activist and author Alice Wong dies at 51
- Mom warns of Christmas gift hazard as daughter recovers in hospital
- They want better health care — so they're turning to crypto startups
- 'I was diagnosed with incurable brain cancer on holiday'
